8 min. Read

Apple hints about future FDA submissions. Trial updates

Issue 165

Welcome back to E&O Fridays, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health.

 E&O Fridays.

Still quiet here in FDA-regulated and pharma-focused digital

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Thirteen secret health tech funding deals
5 min. Read
Oui Therapeutics spun out a virtual clinic. physIQ revs, bankruptcy.
9 min. Read
Fern’s MSK program pricing. Kimberly-Clark’s benefits.
6 min. Read
Three new Medicaid Rx digital therapeutic bills. Trials
5 min. Read
Eight secret health tech funding deals
4 min. Read
Hello Heart’s pricing, guarantees. General Mills’ benefits.
7 min. Read
Highmark won’t pay for every FDA-cleared prescription digital therapeutic. Clinical Trials.
7 min. Read
$120M in secret health tech deals: Pearl Health, Amalgam Rx and more
5 min. Read
Florida Medicaid covers Pear. MedRhythms pivotal. Trials
6 min. Read
Akili layoffs, pipeline changes. DiGA price drop. Trials
7 min. Read
  • First
  • Previous
  • 1 of 30
  • Next
  • Last